Covid-19: US regulator revokes use of Hydroxychloroquine
Nigeria’s NCDC maintained it has not authorized the use of Chloroquine for treatment of COVID-19.
Nigeria’s NCDC maintained it has not authorized the use of Chloroquine for treatment of COVID-19.
NAFDAC has ordered the manufacturing of Chloroquine for an emergency stock for clinical treatment of Coronavirus.
Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |